9780521116565-0521116562-Incentives for Global Public Health: Patent Law and Access to Essential Medicines (Connecting International Law with Public Law)

Incentives for Global Public Health: Patent Law and Access to Essential Medicines (Connecting International Law with Public Law)

ISBN-13: 9780521116565
ISBN-10: 0521116562
Edition: 1
Author: Kim Rubenstein, Matthew Rimmer, Thomas Pogge
Publication date: 2010
Publisher: Cambridge University Press
Format: Hardcover 536 pages
FREE US shipping

Book details

ISBN-13: 9780521116565
ISBN-10: 0521116562
Edition: 1
Author: Kim Rubenstein, Matthew Rimmer, Thomas Pogge
Publication date: 2010
Publisher: Cambridge University Press
Format: Hardcover 536 pages

Summary

Incentives for Global Public Health: Patent Law and Access to Essential Medicines (Connecting International Law with Public Law) (ISBN-13: 9780521116565 and ISBN-10: 0521116562), written by authors Kim Rubenstein, Matthew Rimmer, Thomas Pogge, was published by Cambridge University Press in 2010. With an overall rating of 4.2 stars, it's a notable title among other Patent, Trademark & Copyright (Health Care Delivery, Administration & Medicine Economics, Health Policy, Intellectual Property) books. You can easily purchase or rent Incentives for Global Public Health: Patent Law and Access to Essential Medicines (Connecting International Law with Public Law) (Hardcover) from BooksRun, along with many other new and used Patent, Trademark & Copyright books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.3.

Description

This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book